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Normal steady-state levels of the signalling lipids PI(3,5)P2
and PI(5)P require the lipid kinase FAB1/PIKfyve and its
regulators, VAC14 and FIG4. Mutations in the PIKfyve/
VAC14/FIG4 pathway are associated with Charcot-Marie-
Tooth syndrome and amyotrophic lateral sclerosis in
humans, and profound neurodegeneration in mice.
Hence, tight regulation of this pathway is critical for
neural function. Here, we examine the localization and
physiological role of VAC14 in neurons. We report that
endogenous VAC14 localizes to endocytic organelles in
fibroblasts and neurons. Unexpectedly, VAC14 exhibits a
pronounced synaptic localization in hippocampal neu-
rons, suggesting a role in regulating synaptic function.
Indeed, the amplitude of miniature excitatory postsynaptic
currents is enhanced in both Vac14 / and Fig4 /
neurons. Re-introduction of VAC14 in postsynaptic
Vac14 / cells reverses this effect. These changes in
synaptic strength in Vac14 / neurons are associated
with enhanced surface levels of the AMPA-type glutamate
receptor subunit GluA2, an effect that is due to diminished
regulated endocytosis of AMPA receptors. Thus, VAC14,
PI(3,5)P2 and/or PI(5)P play a role in controlling postsy-
naptic function via regulation of endocytic cycling of
AMPA receptors.
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Introduction
Phosphorylated phosphoinositide (PI) lipids reside on the
cytoplasmic side of eukaryotic membranes and regulate a
diverse array of cellular functions. The sn-3, 4 and 5 positions
of the inositol head group have the potential to be phos-
phorylated in all seven combinations and each type of PI
plays unique roles in mammals. Each PI recruits a distinct set
of protein effectors and regulates multiple cellular events
including membrane traffic (Corvera et al, 1999; Roth,
2004), protein sorting (Saksena et al, 2007), growth factor
signalling (Cantley, 2002), ion homeostasis (Balla, 2006;
Dong et al, 2010), cell survival (Brunet et al, 2001) and cell
motility (Yin and Janmey, 2003).
PI lipids are tightly regulated and inter-converted by an
array of lipid kinases and phosphatases. A conserved protein
complex including PIKfyve/FAB1/PIP5K3 (GenBank acces-
sion # NP_035216), VAC14 (NP_666328) and FIG4/SAC3
(NP_598760) is responsible for the biosynthesis and turnover
of PI(3,5)P2 (Jin et al, 2008; Ikonomov et al, 2009). PIKfyve is
the PI(3)P 5-kinase that phosphorylates PI(3)P to form
PI(3,5)P2 (Gary et al, 1998), whereas FIG4 dephosphory-
lates PI(3,5)P2 back to PI(3)P (Rudge et al, 2004; Duex
et al, 2006a). The presence of both a kinase and a
phosphatase in the same complex allows for tight
regulation of PI(3,5)P2 levels. VAC14, a HEAT repeat
protein, forms a scaffold for formation of the complex and
also brings in other regulatory factors (Jin et al, 2008). Loss of
PIKfyve or VAC14 causes a loss or decrease in PI(3,5)P2
levels, respectively (Duex et al, 2006b; Zhang et al, 2007;
Ikonomov et al, 2011). While knockout of FIG4 might be
predicted to increase PI(3,5)P2, FIG4 also activates PIKfyve
and thus, PI(3,5)P2 is decreased in Fig4
 / fibroblasts
(Chow et al, 2007) and yeast (Duex et al, 2006a).
Interestingly, impairment of PIKfyve activity by either loss
of VAC14 (Zhang et al, 2007) or pharmacological inhibition
with YM201636 (Sbrissa et al, 2012) also causes a decrease
in PI(5)P levels in mammalian cells. Note that the yeast
S. cerevisiae does not produce PI(5)P. In mammals, the
PI(5)P pool could come either from direct phosphorylation
of phosphatidylinositol by PIKfyve (Sbrissa et al, 1999), or
via dephosphorylation of PI(3,5)P2 by myotubularin family
phosphatases (Tronchère et al, 2004); both pathways are
dependent on PIKfyve activity.
The PIKfyve/VAC14/FIG4 complex is critical for endomem-
brane homeostasis and has been implicated in an ever-grow-
ing list of processes. In yeast, PI(3,5)P2 regulates vacuole
fission, vacuole acidification (Bonangelino et al, 1997, 2002;
Gary et al, 1998), retrograde traffic from the vacuole
(Bryant et al, 1998; Dove et al, 2004) and is involved in the
assembly of transcriptional regulators (Han and Emr, 2011).
In metazoans, the PIKfyve/VAC14/FIG4 pathway regulates
endosome-to-trans-Golgi network retrograde transport
(Rutherford et al, 2006), autophagy (Rusten et al, 2007;
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de Lartigue et al, 2009; Ferguson et al, 2009), exocytosis
(Osborne et al, 2008), calcium channel activation (Shen
et al, 2009; Dong et al, 2010) and degradation (Tsuruta
et al, 2009). In plants, the PIKfyve/VAC14/FIG4 pathway is
involved in endocytosis, vacuole formation, auxin
transporter recycling, and pollen development (Hirano and
Sato, 2011; Hirano et al, 2011). It remains to be determined
which of the mammalian pathways are regulated by PI(3,5)P2
and/or PI(5)P.
Analysis of several mouse mutants point to critical roles for
the PIKfyve/VAC14/FIG4 pathway in the central and periph-
eral nervous systems. Vac14 gene trap (Vac14 / ) mice have
half of the normal levels of PI(3,5)P2 and PI(5)P. They
develop normally, yet die perinatally with numerous neural
defects including spongiform-like lesions and increased apop-
tosis in the brain, and intracellular vacuolation in peripheral
neurons (Zhang et al, 2007). Fig4 / (Chow et al, 2007;
Ferguson et al, 2009; Lenk et al, 2011) and Vac14L156R/L156R
(ingls) (Jin et al, 2008), mouse mutants defective in
PI(3,5)P2 and PI(5)P regulation, have similar patterns
of neurodegeneration to that observed in the Vac14 /
mouse.
Importantly, human patients with minor defects in the
PIKfyve/VAC14/FIG4 pathway also display severe neurologi-
cal problems. Mutations in FIG4 are responsible for human
Charcot-Marie-Tooth disease type 4J (CMT4J), a recessive
disorder affecting the peripheral nervous system (Chow et al,
2007; Nicholson et al, 2011). The most common CMT4J allele,
I41T, destabilizes the mutant FIG4 protein and impairs its
binding to VAC14 (Ikonomov et al, 2010; Lenk et al, 2011).
Heterozygous FIG4 mutations have also been identified in
patients with amyotrophic lateral sclerosis (ALS) and primary
lateral sclerosis (PLS), two forms of motor neuron disease
(Chow et al, 2009). These observations suggest that the
PIKfyve/VAC14/FIG4 pathway has specialized functions in
the nervous system.
Defects in multiple neural cell types likely contribute to the
pathologies observed in VAC14/FIG4-deficient mouse mod-
els. Both neurons (Chow et al, 2007; Zhang et al, 2007, 2008;
Katona et al, 2011) and astrocytes (Jin et al, 2008; Ferguson
et al, 2009) are affected by mutations in VAC14 or FIG4.
However, expression of FIG4 in neurons, but not astrocytes,
rescues the spongiform-like lesions, gliosis and early lethality
in Fig4 / mice (Ferguson et al, 2012), emphasizing the
importance of the PIKfyve/VAC14/FIG4 pathway in neuronal
function.
Neurons are highly polarized cells that process electroche-
mical signals by extending long specialized processes—axons
and dendrites—to facilitate information transfer through
neural circuits. Accordingly, the endosomal system in neu-
rons has both general and specialized pathways, such as
long-range trafficking along neurites (Ibáñez, 2007), as well
as specialized recycling in both the presynaptic and
postsynaptic terminals (Kennedy and Ehlers, 2006; Dittman
and Ryan, 2009). These membrane events are critical for
multiple aspects of neuronal function such as neurite
outgrowth, neurotrophic factor signalling and synaptic
plasticity (Lasiecka and Winckler, 2011). However, the role
of PIKfyve/VAC14/FIG4 in neuronal function remains
unknown.
Here, we address the functional significance of the
PIKfyve/VAC14/FIG4 pathway in cultured neurons from the
hippocampus of wild-type and Vac14 / mice. To gain
insight into the cellular distribution of PIKfyve/VAC14/FIG4
pathway, we developed an antibody to VAC14, suitable for
immunofluorescence microscopy, and found that endogen-
ous VAC14 localizes to multiple organelles, consistent with
multiple roles for PI(3,5)P2 in the endomembrane system.
VAC14 partially colocalizes with early endosomes, late endo-
somes, lysosomes and autophagosomes. In neurons, VAC14 is
found in both somatodendritic regions and axons. Notably, a
substantial amount of endogenous VAC14 is present at
synaptic sites, suggesting a role for VAC14 in the regulation
of synaptic efficacy. Indeed, we find that synaptic function is
altered in neurons cultured from Vac14 / and Fig4 /
mice. Both postsynaptic function and surface expression of
AMPA-type glutamate receptors are enhanced in Vac14 /
hippocampal neurons. Expression of VAC14 in Vac14 /
neurons reverses the synaptic phenotype, indicating a cell-
autonomous and post-developmental role for VAC14 in reg-
ulating excitatory synaptic strength. We further show that the
elevated surface AMPA receptor levels in Vac14 / neurons
are due to decreased endocytosis at postsynaptic sites.
Together, our results identify control of PI(3,5)P2 and/or
PI(5)P synthesis as a novel regulatory pathway at synapses
that influences surface levels of glutamate receptors and
synaptic function.
Results
Vac14 / hippocampal neurons exhibit vacuolation,
but otherwise develop normally in culture
Consistent with its importance in the nervous system,
expression of VAC14 is abundant in the brain relative to
other tissues (Supplementary Figure S1A and B). In this
study, we sought insights into the neuronal-specific functions
of the PIKfyve/VAC14/FIG4 complex. We focused on hippo-
campal neurons because VAC14 expression in the hippocam-
pus is similar to other brain regions (Supplementary Figure
S1C) and the hippocampus is largely spared from neurode-
generation, even at the time of death in Vac14 / and
Fig4 / animals (Chow et al, 2007; Zhang et al, 2007).
Hippocampal neurons from Vac14 / embryos remain
viable for several weeks, which enabled us to examine the
impact of Vac14 deletion in these cells.
Although no spongiform lesions were observed in hippo-
campal regions in vivo, cultured Vac14 / hippocampal
neurons developed small vacuoles in the soma as early as
1 day in vitro (DIV) (Supplementary Figure S2A). Similarly to
fibroblasts, the neuronal vacuoles are positive for the late
endosome/lysosome marker LAMP1 and negative for the
early endosome marker EEA1 (Supplementary Figure S2B).
Notably, at the neuron density used (2104 per 1.91 cm2),
vacuoles are also observed in neurites by 12 DIV, suggesting
that VAC14 functions in both the soma and neurites. Vacuole
formation in Vac14 / neurons appears to be activity
independent; the degree of vacuolation in cells subjected to
activity blockade (1 mM TTX, 40 mM CNQX, 20 mM APV) from
DIV3 to DIV18 was similar to that in untreated neurons
(Supplementary Figure S2C).
The presence of vacuoles in neurons lacking VAC14 did not
appear to affect axon and dendrite development in culture, as
assessed using the five stage model (Dotti et al, 1988;
Supplementary Figure S3A). Vac14 / neurons progressed
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from stage I (lamellipodia) to stage IV/V (complicated
networks) at a rate similar to wild-type neurons
(Supplementary Figure S3B), implying normal neurite out-
growth and differentiation.
Subcellular localization of VAC14 in cultured fibroblasts
To determine the sites of action of the PIKfyve/VAC14/FIG4
complex in neurons, we determined the localization of
endogenous VAC14. Previous attempts to localize compo-
nents of the PIKfyve complex in non-neuronal cells relied
on overexpression of tagged proteins, and have produced
divergent results. An earlier study indicated that overex-
pressed, tagged PIKfyve is confined to late endosome/lyso-
some compartments (Ikonomov et al, 2001), whereas other
analyses found tagged FAB1/PIKfyve primarily localized to
early endosomes (Cabezas et al, 2006; Rutherford et al,
2006).
To better understand the endogenous cellular distribution
of the PIKfyve/VAC14/FIG4 complex, we raised a rabbit
polyclonal antibody against full-length human VAC14 pro-
tein. After extensive affinity purification, we obtained a
reagent that, in western blot analysis, revealed a major
band at the expected molecular weight (88 kD) in wild-type
but not in Vac14 / brain (Supplementary Figure S1A). In
wild-type fibroblasts, permeabilized with saponin prior to
fixation, VAC14 was present on punctate organelles distrib-
uted throughout the cytoplasm; these structures were absent
from Vac14 / fibroblast controls (Figure 1A). Nuclear
staining was frequently observed in both wild-type and
Vac14 / cells (Supplementary Figure S4A); thus, the anti-
body is not suitable to test whether VAC14 is also localized in
the nucleus.
To determine the relative distribution of VAC14 on
endosomal and lysosomal membranes, we performed triple
labelling experiments in primary fibroblasts and determined
the distribution of VAC14, EEA1 and LAMP1 puncta
(Figure 1B; Supplementary Figure S4B and F). Consistent
with earlier studies, EEA1 and LAMP1 labelled distinct
compartments. The majority of VAC14 puncta colocalized
with EEA1 (20±5%), LAMP1 (30±5%) or both markers
(19±7%). These triple-labelled puncta likely represent inter-
mediate endosomes. Thus, VAC14, PI(3,5)P2 and potentially
PI(5)P, are present in multiple locations within the endomem-
brane system, including early endosomes, late endosomes
and lysosomes (Supplementary Figure S5). Some VAC14
puncta (31±8%) did not colocalize with either EEA1 or
LAMP1, suggesting that VAC14 may also function on other
compartments.
LAMP1 is present on both late endosomes and lysosomes.
To determine whether VAC14 is found on one or both of these
compartments, we examined VAC14 localization relative to
LBPA (late endosomes) or internalized dextran (lysosomes).
Partial colocalization was observed between VAC14
(15±6%) and LBPA (Figure 1C; Supplementary Figure S4C
and G), which indicates that some VAC14 resides on late
endosomes. To determine whether lysosomes also contain
VAC14, cells were incubated with a fluid phase marker, 70 kD
Texas Red-dextran, and then chased in the absence of dextran
for 24 h to allow it to reach lysosomes. Partial colocalization
was observed between VAC14 (23±9%) and lysosomes
loaded with dextran (Figure 1D; Supplementary Figure S4D
and G), suggesting that some VAC14 is also localized on
lysosomes. Interestingly, the limiting membrane of vacuoles
in Vac14 / fibroblasts is positive for LAMP1, but negative
for LBPA (Figure 1E), implying that the large vacuoles derive
solely from lysosomes.
In metazoans, the PIKfyve/VAC14/FIG4 pathway is
thought to play a role in autophagy, either during fusion of
autophagosomes with endosomes/lysosomes, or recycling of
lysosomes from autolysosomes (Rusten et al, 2007;
de Lartigue et al, 2009; Ferguson et al, 2009). LC3 is a
common marker of autophagosomes. We transfected wild-
type or Vac14 / fibroblasts with LC3-RFP and colabelled
transfected cells with anti-VAC14. VAC14 (17±13%) partially
colocalized with LC3 (Figure 1F; Supplementary Figure S4E
and G), suggesting that autophagosomes may contain
PI(3,5)P2 and/or PI(5)P. Alternatively, these PI(3,5)P2
and/or PI(5)P containing regions may represent the interface
between autophagosomes and endosomes/lysosomes.
Localization of VAC14 in neurons
To determine the localization of VAC14 in neurons, we first
examined its distribution in the soma. In this case, neurons
were not permeabilized with saponin prior to fixation; thus,
the images indicate both membrane bound and cytosolic
pools of VAC14. A significant portion of the VAC14 localized
to punctate structures (Supplementary Figure S6). As in
fibroblasts, VAC14 puncta colocalized both with the early
endosome marker, EEA1 (Supplementary Figure S6A),
and with the late endosome/lysosome marker, LAMP2
(Supplementary Figure S6B).
To test whether VAC14 is present in dendrites, hippocampal
neurons were labelled with antibodies against VAC14
and against MAP2, a microtubule-associated protein that is
highly expressed in dendrites but not in axons. Notably,
discrete VAC14 puncta were found in MAP2-positive den-
drites (Figure 2A; Supplementary Figure S7A). Moreover,
another pool of VAC14 puncta was evident in MAP2-negative
neurites, implying an axonal localization. To test this further,
we labelled neurons with anti-VAC14 and anti-TAU-1, which
preferentially labels axons in younger cultures (Horton
et al, 2005). Again, VAC14 puncta were present in TAU-1-
labelled axons (Figure 2A; Supplementary Figure S7A),
although this axonal VAC14 pool was less prominent
than the dendritic pool. In neurites, VAC14 puncta partially
colocalized with both EEA1 (23±12%) and LAMP1
(29±9%) (Figure 2B; Supplementary Figure S7B and C),
suggesting that VAC14 in neuronal processes functions in
pathways that involve early and late endosomes as well as
lysosomes.
Endogenous VAC14 localizes to synapses
Interestingly, the most striking colocalization was observed
between VAC14 and synaptic markers. A substantial number
of VAC14 puncta colocalized with the presynaptic terminal
markers synapsin, synaptotagmin and VAMP/synaptobrevin
(Figure 2C; Supplementary Figure S7D). To test whether
VAC14 colocalizes with excitatory synapses, we performed
triple labelling against VAC14, vGlut1 (the glutamate trans-
porter on presynaptic vesicles), and the postsynaptic scaffold-
ing protein PSD95. VAC14 puncta colocalized extensively
with vGlut1/PSD95 double-positive puncta (Figure 2D;
Supplementary Figure S7E), suggesting a role for VAC14 in
excitatory synapse function.
VAC14 regulates synaptic function
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Altered synaptic function in cultured Vac14 / neurons
To examine a functional role for the PIKfyve/VAC14/FIG4
pathway at the synapse, we measured miniature excitatory
postsynaptic currents (mEPSCs) in pyramidal-like neurons
from Vac14 / hippocampal cultures and corresponding
wild-type controls. mEPSCs represent unitary synaptic cur-
rents mediated by the spontaneous fusion of single synaptic
vesicles, and are often used to reveal functional changes in
synaptic strength. Pyramidal-like neurons with little to no
vacuolation were targeted for electrophysiology. Given the
neurodegeneration observed in other regions of the brain at
the time of birth, one might expect synaptic function to be
diminished in Vac14 / neurons. Surprisingly, mEPSCs from
Vac14 / neurons displayed a significant increase (24±6%)
in amplitude relative to wild-type mEPSCs (Figure 3A and B),
suggesting an inhibitory role for VAC14 in synaptic function.
We found no difference in mEPSC frequency or decay time in
Vac14 / mEPSCs (Figure 3C–E). In a parallel experiment,
we found mEPSC amplitude was similarly increased in
Fig4 / mice (Figure 3F and G), which also have reduced
PIKfyve kinase activity. Together, these data suggest that the
increase in mEPSC amplitude in both Vac14 / and Fig4 /
neurons results from defects in PI(3,5)P2 and/or PI(5)P
synthesis.
Although we found no change in mEPSC frequency in
either Vac14 / (Figure 3C) or Fig4 / neurons
(Figure 3H), VAC14 is localized to axons (Figure 2A), and
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Figure 1 Endogenous VAC14 partially colocalizes with multiple endocytic organelles. (A) Polyclonal VAC14 antibody recognizes punctate
structures in wild-type cells. Fibroblasts were permeabilized with saponin followed by fixation, then labelled with anti-VAC14 antibody. Bottom
panels, DIC images. (B) In fibroblasts, endogenous VAC14 colocalizes with both EEA1 and LAMP1. Wild-type fibroblasts were triple labelled
with rabbit anti-VAC14, chicken anti-EEA1 and rat anti-LAMP1. The majority of VAC14 colocalized with either EEA1 (yellow arrows) or LAMP1
(turquoise arrows). Some VAC14 colocalized with both (white arrows) or neither (green arrow) markers. (C) VAC14 partially colocalizes with
the late endosome marker LBPA (arrow). Fibroblasts were double labelled with rabbit anti-VAC14 and mouse anti-LBPA. (D) VAC14 partially
colocalized with lysosomes (arrow). To label lysosomes, prior to fixation, fibroblasts were pulsed with Texas Red-Dextran (Mw 70kD) for 1 h
and chased in the absence of dextran for 24 h. (E) The limiting membrane of vacuoles in Vac14 / cells is positive for LAMP1 while negative
for LBPA, suggesting a lysosomal origin. Vac14 / fibroblasts were double labelled with rat anti-LAMP1 and mouse anti-LBPA. (D, E) DAPI
(blue) used to label nuclei. (F) VAC14 partially colocalizes with LC3-RFP puncta (arrows). Fibroblasts transfected with LC3-RFP were fixed and
labelled with anti-VAC14. (A–F) Bar¼ 10 mm.
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function. The enlargement of endocytic compartments in
Vac14 / cells (Zhang et al, 2007) also suggested that the
increase in mEPSC amplitude in Vac14 / neurons could
have resulted from increased glutamate release by enlarged
presynaptic vesicles (increased quantal content). To examine
this possibility, we performed transmission electron
microscopy on thin sections from the hippocampus and
hindbrain of wild-type and Vac14 / mice at P0. The
hindbrain was included in these studies because it is the
most vacuolated brain region in the Vac14 / animal at the
time of death. We found similar synaptic vesicle diameter in
wild-type and Vac14 / presynaptic terminals of both brain
regions (Figure 4A and B).
Despite similar mEPSC frequency between Vac14 / and
wild-type neurons, we observed that the number of excitatory
synapses in the first 100 mm of Vac14 / dendrites was
modestly but significantly decreased (Figure 4C and D).
This discrepancy raised the possibility that although
Vac14 / neurons have fewer presynaptic inputs, the term-
inals may have elevated neurotransmitter release probability.
To further examine presynaptic function, we measured the
probability of synaptic vesicle release by recording postsy-
naptic NMDA receptor mediated currents in the presence of
the use-dependent NMDA receptor antagonist, MK801
(Huettner and Bean, 1988). The degree of blockade is
proportional to the number of presynaptic vesicles that
release glutamate in response to stimulation (Rosenmund
et al, 1993). We found that Vac14 / neurons showed
greater blockade than wild-type neurons (Figure 4E and F)
which suggests an enhancement of release probability in
Vac14 / neurons. Given that the frequency of mEPSCs
was similar, the expected change in mEPSC frequency
was likely masked by the decrease in synapse number.
Together, these results suggest that the PIKfyve/VAC14/FIG4
pathway modulates neurotransmitter release at the presynap-
tic terminal.
VAC14 levels are higher in dendrites than axons. To test
whether increased mEPSC amplitude in Vac14 / neurons is
due to loss of VAC14 in the postsynaptic neuron, we trans-
fected neurons with plasmids encoding Citrine-tagged human
VAC14. For these experiments, we used calcium phosphate-
based transfection because the low transfection efficiency
(B1% of cells) ensures that the few neurons that express
VAC14 in Vac14 / cultures received the excitatory synaptic
contacts from neurons that lack VAC14. Thus, mEPSCs
recorded from transfected neurons measure the effect of
restoring VAC14 to the postsynaptic cell. We found VAC14
expression reversed the increase in mEPSC amplitude
observed in Vac14 / relative to wild-type neurons, whereas
expression of Citrine alone did not (Figure 5). Moreover, even
in wild-type neurons, overexpression of Citrine-VAC14 sig-
nificantly depressed mEPSC amplitude relative to expression
of untransfected neighbours, suggesting that synaptic
strength is bidirectionally regulated by the levels of VAC14
in postsynaptic neurons. Together, these results strongly






















Figure 2 VAC14 is found in both dendrites and axons, and colocalizes with endocytic and synaptic markers in hippocampal neurons.
(A) Wild-type and Vac14 / neurons were double labelled with rabbit anti-VAC14 and mouse anti-MAP2 (dendrites) or mouse anti-TAU-1
(axons). Arrows indicate the localization of VAC14 on dendrites (MAP2-positive and TAU-negative neurites). Arrowheads indicate the
localization of VAC14 on axons (MAP2-negative and TAU-1-positive neurites). Bar¼ 10 mm. (B) VAC14 partially colocalizes with EEA1 or
LAMP1 in the neurites (arrows). Wild-type and Vac14 / neurons were triple labelled with rabbit anti-VAC14, chicken anti-EEA1 and rat anti-
LAMP1. Bar¼ 5mm. (C) VAC14 displays significant colocalization with several synaptic markers: synapsin, synaptotagmin and synaptobrevin.
Wild-type and Vac14 / neurons were double labelled with rabbit anti-VAC14 and guinea pig anti-synapsin, mouse anti-synaptotagmin or
mouse anti-synaptobrevin. Bar¼ 5mm. (D) VAC14 partially localizes at excitatory synapses (labelled with both the synaptic vesicle glutamate
transporter vGlut1 and postsynaptic marker PSD95). Wild-type and Vac14 / neurons were labelled with rabbit anti-VAC14, mouse anti-
PSD95 and guinea pig anti-vGlut1. Arrows indicate examples of colocalization. (C, D) Lower panels show straightened dendrites from
corresponding top panels. Bar¼ 5mm.
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Surface AMPA receptors are elevated in Vac14 /
hippocampal neurons
mEPSCs are dominated by currents through AMPARs loca-
lized on the postsynaptic membrane (Gong and De Camilli,
2008). Thus, the increase in mEPSC amplitude in Vac14 /
neurons could result from changes in the number of surface
AMPA receptors. Under basal conditions, most AMPA
receptors in the hippocampus are heterotetramers of the
GluA2 and GluA1 subunits (Lu et al, 2009). By western
blot, we found similar levels of total GluA2 between wild-
type and Vac14 / neurons (Supplementary Figure S8). To
test if the level of GluA2 at the cell surface was different,
intact cultured neurons were incubated with an antibody
against an extracellular epitope of GluA2 (Mouse IgG2a,
MAB397; Chemicon), followed by fixation and incubation
with a fluorescent secondary antibody under non-permeabi-
lizing conditions. Surface GluA2 puncta were quantified
using immunofluorescence microscopy (Figure 6A). In both
wild-type and Vac14 / neurons, there was a wide range in
intensities of surface GluA2 puncta. However, in Vac14 /
neurons, the average and median surface GluA2 intensities
were 34 and 17% higher, respectively, relative to wild-type
neurons. The medians differed significantly with 95% con-
fidence, indicated by the non-overlapping notches surround-
ing the medians in the box plot. Moreover, the cumulative
distribution of surface GluA2 puncta intensities was right-
shifted in Vac14 / neurons (Figure 6B). These data indicate
that surface GluA2 levels are increased in Vac14 / neurons,
which likely accounts for the increased amplitude of mEPSCs.
In an independent approach, we measured the ratio of surface
to total GluA2 in dendrites. Surface GluA2 was labelled as
described above. Then neurons were permeabilized and
labelled with a C-terminal GluA2 antibody (Rabbit pAb, AB1768;
Chemicon) to identify total GluA2. We found that the ratio of
surface to total GluA2 was increased in Vac14 / dendrites,








































































































Figure 3 Loss of VAC14 or FIG4 leads to an increase in excitatory synaptic function. (A) Representative mEPSC recordings of wild-type
(N¼ 32) and Vac14 / neurons (N¼ 32). (B) Mean mEPSC amplitude in Vac14 / neurons is larger than in wild-type neurons,
20.86±1.03pA versus 16.83±0.91 pA, respectively. *P¼ 0.0045, t-test. (C) Mean mEPSC frequency is similar in wild-type (1.21±0.26Hz)
and Vac14 / (1.16±0.24Hz) neurons. (D, E) Summary of mEPSC kinetics in wild-type and Vac14 / neurons. (D) Individual mEPSCs
overlaid. Thick lines show the mean trace. Dashed line is aligned to the mean peak inward current of Vac14 / mEPSC. Scaled overlay
shows similar kinetics between wild-type and Vac14 / mEPSCs. (E) Mean mEPSC decay is similar between wild type (3.80±0.15ms) and
Vac14 / (3.69±0.14ms). (F) Representative mEPSC traces of wild-type (Fig4þ /þ ) (N¼ 12) and Fig4 / neurons (N¼ 14). (G) Mean
mEPSC amplitude in Fig4 / neurons is larger than in Fig4þ /þ neurons (14.64±0.39 pA versus 18.73±1.38 pA, respectively, *P¼ 0.0164,
t-test). (H) Mean mEPSC frequency is similar in Fig4þ /þ and Fig4 / (0.99±0.22Hz versus 0.92±0.28Hz, respectively, P¼ 0.8542, t-test).
Error bars are standard error of the mean (s.e.m.).
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suggest that GluA2 receptors are expressed in Vac14 /
neurons at similar levels, but accumulate on the surface.
Trafficking of AMPA receptors is altered in Vac14 /
neurons
GluA2 undergoes constant cycling between the surface and
internal pools; once internalized, GluA2 may either be
degraded in lysosomes or recycled back to the plasma mem-
brane. Perturbations in endocytosis, recycling or degradation
could lead to an accumulation of surface receptors in
Vac14 / neurons. To measure the rate of endocytosis of
AMPA receptors, we performed live labelling of surface
GluA2 with anti-GluA2 antibody and then stimulated endo-
cytosis via addition of NMDA (Figure 7A). After 10min,
surface bound GluA2 antibodies were stripped by a brief
wash in low pH solution, such that only internalized GluA2
antibodies were detected after fixation and permeablization.
Leupeptin was present throughout to prevent lysosomal











































Wild type Vac14 –/–
















































































VAC14 regulates synaptic function
Y Zhang et al
3448 The EMBO Journal VOL 31 | NO 16 | 2012 &2012 European Molecular Biology Organization
degradation. Notably, the number of internalized GluA2
puncta was decreased by 30% in dendrites in Vac14 /
neurons (Figure 7B and E). Total levels of internalized
GluA2 puncta in the soma and dendrites were reduced to
71 and 56%, respectively, compared to wild type (Figure 7C
and D). These results are consistent with an endocytosis
defect in Vac14 / neurons. To determine whether interna-
lized GluA2 still enters the degradation pathway in Vac14 /
neurons, we further measured the proportion of internalized
GluA2 puncta that colocalized with the late endosomal and
lysosomal marker LAMP1 (Supplementary Figure S9).
Though fewer internalized GluA2 puncta were observed in
Vac14 / neurons, a similar proportion exhibited colocali-















































Figure 5 Restoration of VAC14 eliminates the increase in mEPSC amplitude in Vac14 / neurons. (A) Examples of mEPSC recordings of wild-
type and Vac14 / neurons that were sham-transfected, expressed VAC14-Citrine or Citrine alone. (B) Quantification of mEPSC amplitude
normalized to sham-transfected wild-type neurons shows that there is an inverse relationship between level of VAC14 expression and mEPSC
amplitude. In wild-type neurons, VAC14 overexpression leads to a decrease in amplitude. The increase in mEPSC amplitude in Vac14 /
neurons is reduced by re-introduction of VAC14. Neurons transfected with Citrine were similar to untransfected wild type. One-way ANOVA test
was used to compare mEPSC amplitudes (F(5, 12.3), P¼ 8.2710 9). *Individual comparisons between untransfected and VAC14-transfected
wild-type and untransfected and VAC14-transfected Vac14 / neurons were significant using Tukey-Kramer honestly significant difference
(HSD) criterion. WT, wild type; KO, Vac14 / . Error bars, s.e.m.
Figure 4 Presynaptic probability of release is enhanced in Vac14 / neurons. (A, B) Synaptic vesicles from Vac14 / are not larger than
synaptic vesicles observed in brains from wild type. (A) Electron microscopy of excitatory synapses, evident by the thickening of the
postsynaptic membrane, in wild-type and Vac14 / hippocampus and hindbrain. Bar¼ 100nm. (B) Quantitation of the diameter of synaptic
vesicles. Cumulative probability distribution of synaptic vesicle diameter. No significance difference was found between wild type and
Vac14 / by a two-sample Kolmogorov-Smirnov test (kstest2, Matlab) (hippocampus, P¼ 0.32; hindbrain, P¼ 0.46). Three wild-type and
three Vac14 / animals were analysed. Hindbrain: N¼ 567 vesicles from 33 terminals for wild type and 388 vesicles from 29 terminals for
Vac14 / . Hippocampus: N¼ 433 vesicles from 33 terminals for wild type and 66 vesicles from 15 terminals for Vac14 / . (C, D) The
number of synapses is decreased in Vac14 / neurons. (C) Wild-type and Vac14 / hippocampal neurons were triple labelled with rabbit
anti-MAP2 (blue), mouse anti-PSD95 (red) and guinea pig anti-vGlut (green). Examples of straightened dendrites are shown. Bar¼ 5mm.
(D) Quantitation of the number of synapses on the first 100mm of dendrites starting from the soma. The numbers of synapses were normalized
to the average of wild type. Vac14 / neurons had fewer synapses (N¼ 91 for wild type and 71 for Vac14 / ) (*P¼ 1.710 4, t-test). Error
bars, s.e.m. (E, F) Presynaptic probability of release is increased in Vac14 / neurons. NMDA currents were pharmacologically isolated from
AMPA and GABAA mediated currents and recorded at  70mV (solution contained zero Mg
2þ ). An extracellular stimulating electrode was
placed locally and used to stimulate vesicle release in afferent axons. Once a stable response was obtained, 20mM MK801, an open-channel
blocker of NMDA receptors, was added to the bath for 5min without stimulation. Then, 200 stimulations were delivered and amplitude of the
current measured (mean amplitude is shown by filled squares). In the presence of MK-801, the current is progressively blocked. The data for
each genotype were fitted with a double exponential curve. The rate of progressive blockade of NMDA current was significantly greater in
Vac14 / neurons; mean amplitude of the 2–11 stimulations is significantly lower in Vac14 / neurons. *P¼ 0.0217, Anova1 (Matlab).
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Vac14 / ). This suggests that the transport of AMPA recep-
tors late in the endocytic pathway is normal in Vac14 /
neurons. In addition, we tested whether the reduction in
internalized puncta was also due to enhanced recycling back
to the surface. We transfected neurons at DIV12 with plas-
mids encoding super-ecliptic pHluorin-tagged GluA1 (Kopec
et al, 2006), which are strongly fluorescent when exposed to
the neutral pH of the extracellular space. At DIV14, we
measured the rate of internalization and recycling of
pHluorin-GluA1 following NMDA stimulation (Figure 8).
Five minutes of NMDA stimulation markedly reduced the
intensity of pHluorin-GluA1. Following wash-out, fluores-
cence recovered to baseline levels as internalized receptors
recycled back to the plasma membrane (Figure 8A–D). The
magnitude of NMDA-dependent internalization of GluA1 was
diminished in Vac14 / neurons (Figure 8E), again suggest-
ing reduced receptor endocytosis in these neurons. To mea-
sure the rate of recycling, we calculated the time point after
NMDA stimulation at which fluorescence intensity recovered
to 50% of the pre-NMDA baseline. Whereas GluA1 interna-
lization was reduced in Vac14 / neurons, we found no
difference in the rate of recycling relative to wild type
(Figure 8F). These results suggest that the initial steps in
AMPA receptor endocytosis, rather than post-endocytic
sorting, represent the most prominent trafficking defect
accompanying loss of VAC14. Together, our findings suggest
that the PIKfyve/VAC14/FIG4 pathway regulates excitatory
synapse function largely via modulation of AMPA receptor
endocytosis (Figure 9).
Discussion
VAC14 modulates synaptic activity in hippocampal
neurons
VAC14 is present in neuronal dendrites and axons and
exhibits extensive colocalization with synaptic markers.
Thus, the PIKfyve/VAC14/FIG4 pathway likely impacts the
synapse at multiple levels, including modulation of both
presynaptic and postsynaptic function. Although here we
focused on postsynaptic VAC14, our results suggest that
there are also effects on presynaptic function. Thus, while
mEPSC frequency is unaltered in Vac14 / neurons, MK801
use-dependent block of NMDA receptor currents is acceler-

























































































Figure 6 Surface GluA2 levels increase in Vac14 / neurons. (A) Surface GluA2 was labelled by incubation of intact neurons with mouse
anti-GluA2 antibody. Arrows highlight the dendrite used for analysis (enlarged in lower panels). Intensity presented in the ‘fire’ LUT colour
scheme. (B) Quantitation of the intensity of GluA2 puncta, normalized to the wild-type mean. The relative intensity values from wild-type and
Vac14 / neurons are presented as a cumulative distribution. A Kolmogorov-Smirnov test demonstrates that the data sets differ significantly;
P¼ 1.11034. The median of each data set also differ significantly (box plot shown in insert). Box, interquartile range; line, median; square,
mean; non-overlapping notches indicate that the two medians are statistically different at the 5% significance level; whiskers, minimum and
maximum of the data within 1.5 times the length of the box. N¼ 5272 for wild type and 4756 for Vac14 / . Error bars, s.e.m. (C) Surface
GluA2 subunits accumulate on the surface of Vac14 / dendrites. Top three panels (wild type) and middle three panels (Vac14 / ) dendrites
(left to right) show surface GluA2, total GluA2, and the dendritic marker, MAP2. Yellow arrows highlight dendrites analysed. Bottom panels
show the merged image of the straightened dendrite (left) and MAP2 (right). (D) The ratio of surface to total GluA2 is increased in Vac14 /
dendrites (1.32±0.052) relative to wild type (1.0±0.0364). *P¼ 6.836107, two-sample t-test. Scale bar¼ 10 mm. Error bars¼ s.e.m.
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release probability. Consistent with a presynaptic role for
PI(3,5)P2 and/or PI(5)P, an earlier report identified C. elegans
FIG4 at presynaptic sites in a large scale RNAi screen
(Sieburth et al, 2005). An increase in probability of
presynaptic vesicle fusion with the plasma membrane fits
with a previous study demonstrating enhanced granule
exocytosis following knockdown of PIKfyve in cultured
chromaffin and PC12 cells (Osborne et al, 2008). This
pathway may be interacting directly with exocytic
machinery. Alternatively, it is possible that voltage-gated
calcium channels or other membrane proteins that are
important for membrane excitability are more highly
expressed on the surface of Vac14 / neurons, which
causes increased calcium influx in response to
depolarization.
The presence of VAC14, and its lipid products, in the
postsynaptic terminal is consistent with earlier findings that
VAC14 interacts with nNOS (Lemaire and McPherson, 2006),
which interacts with the postsynaptic scaffolding protein
PSD95 (Tochio et al, 2000). In addition, MTMR2, a
phosphatase that acts on PI(3,5)P2 in vitro and likely
in vivo, also interacts with PSD95 (Lee et al, 2010). That
VAC14 levels in the somatodendritic region are significantly
higher than in axons, strongly suggested that the PIKfyve/
VAC14/FIG4 pathway controls critical aspects of postsynaptic
function. Indeed, we found that genetic deletion of VAC14 is
accompanied by enhanced mEPSC amplitude. Importantly,
postsynaptic expression of VAC14 rescues this defect,
strongly suggesting that postsynaptic loss of VAC14 is
responsible for the enhanced mEPSC amplitude. Moreover,
Fig4 / neurons exhibited a similar increase in mEPSC
amplitude, strengthening the argument that PIKfyve/
VAC14/FIG4 pathway, and their lipid products PI(3,5)P2
and/or PI(5)P, play a role in postsynaptic function.
AMPA receptor trafficking in Vac14 / neurons
Our results further indicate that VAC14 regulates postsynaptic



































































































































Figure 7 GluA2 endocytosis is reduced in Vac14 / hippocampal neurons. (A) Diagram of experiment. Wild-type or Vac14 / hippocampal
neurons were treated with the lysosomal protease inhibitor leupeptin, then live labelled with mouse GluA2 antibodies to label those receptors
exposed to the cell surface. Endocytosis was stimulated with 50mM NMDA for 10min. Then any remaining surface-exposed GluA2 antibody
was removed with an acid wash. Neurons were then fixed and labelled with Alexa 555 anti-mouse IgG. (B) Example of internalized GluA2.
Intensity presented in the ‘fire’ LUTcolour scheme. Bar¼ 10 mm. (C) Total internalized GluA2 in the soma was decreased in Vac14 / neurons
(N¼ 55 for wild type and 42 for Vac14 / , *P¼ 2.7310 5, t-test). (D) Total internalized GluA2 in the dendrites was decreased in Vac14 /
neurons (N¼ 57 for wild type and 61 for Vac14 / , *P¼ 8.3310 5, t-test). (E) The number of internalized GluA2 puncta were decreased in
Vac14 / neurons (N¼ 57 for wild type and 61 for Vac14 / , *P¼ 5.9110 8, t-test). A fixed length (35mm from the soma) was used for
dendrites in (D) and (E). Error bars, s.e.m.
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Surface levels of AMPA receptors are tightly controlled by
trafficking to and from the cell interior. Consistent with
increased mEPSC amplitude, steady-state levels of surface-
exposed AMPA receptors are elevated in Vac14 / neurons.
Using two independent methods, we found that AMPA
receptor internalization following NMDA receptor activation
is defective in Vac14 / neurons. The total levels of
regulated endocytosed AMPA receptors, quantified from in-
ternalized GluA2 puncta or amplitude of change in pHluorin-
GluA1 fluorescence, are reduced in Vac14 / neurons,
which likely accounts for the elevated surface AMPA receptor
levels. This endocytosis defect is consistent with the finding
that internalization of transfected GluA2 is reduced in cortical
neurons after siRNA knockdown of PIKfyve (Tsuruta et al,
2009). Conversely, MTMR2 knockdown, which is predicted to
increase PI(3,5)P2 levels, enhances AMPA receptor endocytosis
(Lee et al, 2010). Together, these findings suggest a new role for
PI(3,5)P2 and/or PI(5)P, and downstream effector(s), early in
the endocytic pathway. Though general endocytosis could be
regulated by these signalling lipids, Tsuruta et al (2009) found
that the internalization of Cav1.2, but not Kv1.2, was affected
by PIKfyve knockdown; thus, the PIKfyve/VAC14/FIG4
pathway may play a more selective role in endocytosis of
particular membrane proteins.
NMDA
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Figure 8 Endocytosis of AMPA receptors is reduced in Vac14 / neurons. Cultured hippocampal neurons were transfected with pH-GluA1and
mCherry at DIV12. At DIV14, cells were placed on the microscope stage and perfused with normal extracellular buffer. Images were acquired
once per minute for a 10-min baseline, then switched to NMDA stimulation buffer for 5min to stimulate internalization. Then, following
replacement of the NMDA stimulation buffer with normal buffer, monitored for recycling back to the cell surface. The pHluorin fluorescence
was imaged at 488nm excitation, while mCherry fluorescence was imaged at 559 nm excitation, through a  60 oil objective at a rate of one
image per minute. (A) Representative full-frame images of wild-type and Vac14 / neurons during baseline (0–10min), NMDA stimulation
(11–15min) and recovery after wash out (16–55min). (B) Changes in pH-GluA1 fluorescence were calculated from straightened dendrites
isolated from full-frame images. (C) Wild-type and Vac14 / neurons exhibited similar recovery to baseline levels. (D) Average time course
for percent change in pH-GluA1 fluorescence, normalized to average baseline intensity. (E) Amplitude of change in fluorescence after wash-out
of NMDA is decreased in Vac14 / neurons compared to wild type (wild type, 66.72±4.93%; Vac14 / 44.68±7.10%). (F) t1/2 recycling rate
after NMDA removal is normal. *P¼ 0.0224, Two-sample t-test, n¼ 11–14. Error bars, s.e.m.
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While VAC14 is localized throughout the endocytic path-
way, we found that the recycling and degradative trafficking
of AMPA receptors are normal in Vac14 / neurons.
Similarly, EGF receptors traffic normally to lysosomes in
Vac14 / fibroblasts (Zhang et al, 2007), and EGF receptor
trafficking is also unaffected by siRNA knockdown of PIKfyve
(Rutherford et al, 2006), or overexpression of a dominant-
negative mutant PIKfyve (Ikonomov et al, 2003), although
EGF receptor degradation is slowed when a PIKfyve inhibitor
is used (de Lartigue et al, 2009). Importantly, since Vac14 /
cells have half of the normal levels of PI(3,5)P2 and PI(5)P, it
remains possible that different trafficking steps have distinct
sensitivities to the extent of loss of PI(3,5)P2 and/or PI(5)P.
Future work is needed to determine if AMPA receptor
trafficking late in the endocytic pathway is affected if the
PIKfyve/VAC14/FIG4 pathway is inhibited further.
Potential roles of VAC14 in learning and memory
AMPA receptor expression at synapses is regulated to modify
synaptic efficacy in the context of long-term potentiation
(LTP) and long-term depression (LTD) (Song and Huganir,
2002), as well as homeostatic control of synaptic function
driven by persistent changes in neuronal activity (Turrigiano,
2008). Rab5, which likely acts in pathways that are also
regulated by PIKfyve (Jefferies et al, 2008), is similarly
involved in postsynaptic glutamate receptor trafficking and
is required for LTD (Brown et al, 2005), raising the possibility
that dynamic control of PI(3,5)P2 and/or PI(5)P synthesis
contributes to these forms of synaptic plasticity as well.
It is now of interest to assess whether, in addition to the
more severe neurophysiological outcomes that accompany
PIKfyve/VAC14/FIG4 deficiency, perturbations of the
PI(3,5)P2 and/or PI(5)P-related signalling pathways underlie
defects in learning and memory. The Fig4-I41T Tg705
transgenic line that survives to 3 months of age with a
reduced extent of spongiform degeneration could be useful
for this purpose (Lenk et al, 2011).
Excitotoxicity in Vac14 / neurons
Excitotoxicity has been implicated in many acute and chronic
neurological diseases such as stroke (Rothman and Olney,
1986) and ALS (Beal, 1992; Rothstein et al, 1992; Martin,
2010). The increased synaptic efficacy in cultured Vac14 /
neurons also raises the question of whether excitotoxicity
contributes to the neurodegeneration phenotypes observed in
VAC14/FIG4-deficient mouse models. Consistent with this
idea, PIKfyve overexpression has been shown to protect
cultured neurons against excitotoxicity (Tsuruta et al,
2009). In this case, it was postulated that an increase in
PIKfyve activity led to downregulation of voltage-gated
calcium channels and of GluA2, and possibly other as yet
undetermined channels and transporters.
Endogenous VAC14 localizes to multiple compartments
in the endomembrane system
A common view in recently published reviews is that
PI(3,5)P2 is confined to late endosomes, and has little overlap
with its precursor, PI(3)P, which is thought to be confined to
early endosomes. However, in fibroblasts, using an antibody
to endogenous VAC14, we found that VAC14 was equally
distributed between early and late endosomes as well as
lysosomes, with some localization to autophagosomes.
Assuming that the location of VAC14 on membranes reflects
the distribution of PI(3,5)P2 and/or PI(5)P, we predict that
these lipids may regulate pathways that emanate from each of
these organelles. VAC14 also localizes to punctate spots that
contain neither EEA1 nor LAMP1, which suggests that there
are as yet undetermined organelles that contain PI(3,5)P2 and
PI(5)P. We also found that AMPA receptor internalization and
evoked presynaptic vesicle release are altered in the absence
of VAC14, which suggests novel roles for PIKfyve/VAC14/
FIG4, or their downstream effectors, near the plasma mem-
brane. At present, it remains to be determined whether these
effects are specific to neurons or whether the PIKfyve/
VAC14/FIG4 pathway regulates selected events near the
plasma membrane in other cell types.
In summary, our paper describes a critical new role for
VAC14 and, by implication, PI(3,5)P2 and/or PI(5)P, in reg-
ulating synaptic function in neurons. Future work will eluci-
date specific molecular pathways controlled by PI(3,5)P2
and/or PI(5)P and may provide insights into the treatment
of human neuropathies that can be mitigated via regulation







































Figure 9 Model of trafficking defects that promote the elevation of surface AMPA receptors in Vac14 / neurons. Endocytosis of surface
GluA2 is diminished in Vac14 / neurons compared with wild type (1), while no defects were detected in recycling of internal GluA2 to the
cell surface (2) or membrane transport late in the endocytic pathway (3). Note that in the absence of VAC14, FIG4 is destabilized (Lenk et al,
2011). EE, early endosomes; LE, late endosomes; RE, recycling endosomes.
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modulate the levels of these lipids might lead to new thera-
pies for several types of neurological disorders.
Materials and methods
Ethics statement
All animal use was performed in compliance with guidelines of the
University Committee on Use and Care of Animals of the University
of Michigan and National Institutes of Health.
Electrophysiology
Whole-cell patch clamp recordings were performed with an
Axopatch 200B amplifier from 13 to 15 DIV cultured hippocampal
pyramidal-like neurons bathed in an extracellular solution contain-
ing 119mM NaCl, 5mM KCl, 2mM CaCl2, 2mM MgCl2, 30mM
glucose, 10mM HEPES (pH 7.4) plus 1mM TTX and 10mM bicucul-
line to isolate glutamatergic mEPSCs. Internal pipette solution
contained 100mM caesium gluconate, 0.2mM EGTA, 5mM
MgCl2, 40mM HEPES, 2mM Mg-ATP, 0.3mM Li-GTP, 1mM QX-
314 (pH 7.2). Pipette resistance ranged from 3 to 5MO. Neurons
with a pyramidal-like morphology were targeted for analysis. For
Vac14 / neurons, pyramidal-like neurons with few to no vacuoles
were targeted for analysis. Neurons were voltage clamped at
 70mV, and series resistance was not compensated. mEPSC
amplitude and frequency were analysed offline using Minianalysis
(Synaptosoft). Average traces and statistical analysis was performed
in Matlab (Mathworks). Statistical differences between control and
experimental conditions were determined by ANOVA and Tukey-
Kramer honestly significant difference (HSD) test.
In order to measure probability of evoked synaptic vesicle release
in presynaptic terminals forming synapses onto wild-type or
Vac14 / neurons, 24 h after transfection, warm (371C), 0Mg2þ
solution was applied to the bath: 125mM NaCl, 2.5mM KCl, 5mM
HEPES, 2mM CaCl2, 33mM D-Glucose, pH 7.4). AMPA receptor
antagonist, CNQX (20 mM), and GABAA receptor antagonist, bicu-
culline (10 mM), were included to isolate NMDA receptor currents.
Neurons were voltage clamped at  70mV and evoked excitatory
postsynaptic currents were measured by positioning a stimulating
electrode close to the neuron. Once a stable response was obtained,
MK801 (20mM), a use-dependent antagonist for NMDA receptors,
was applied to the bath for 5min without stimulation. Following
wash-in, 200 stimulations at 0.33Hz were delivered in the presence of
MK801. The peak of the NMDA receptor current was measured for
each and normalized to the first response following MK801 wash-in.
Endocytosis assay
Neurons were treated with 20mM leupeptin for 30min before live
labelling with mouse GluA2 antibodies diluted in normal medium
with leupeptin for 15min. After washing with neurobasal medium,
neurons were incubated in normal medium supplemented with
50mM NMDA and 20 mM leupeptin for 10min. Endocytosis was
stopped by washing in cold 1 PBS with 0.1mM CaCl2 and 1mM
MgCl2. Surface bound GluA2 antibodies were stripped with 0.5M
NaCl/0.2M acetic acid for 4min on ice. Neurons were fixed in 2%
paraformaldehyde and 2% sucrose for 15min and permeabilized
with 0.1% Triton X-100 for 5min. After blocking with 2% BSA,
neurons were incubated with Alexa 555 anti-mouse secondary
antibody for 1 h.
To examine the degradation pathway, neurons were incubated
with rat anti-Lamp1 antibodies and then Alexa 488 anti-rat and
Alexa 555 anti-mouse secondary antibodies.
Endocytosis and recycling assay
Neurons were transfected at DIV12 by Calcium Phosphate and
pHluorin-GluA1 endocytosis and recycling live-imaging assays were
performed 36–48h post transfection. Mattek dishes were placed on
the stage of the confocal microscope and perfused with normal
extracellular buffer (25mM HEPES, 120mM NaCl, 5mM KCl, 2mM
CaCl2, 2mM MgCl2, 30mM D-glucose, 1mM TTX, pH 7.4). Images
were acquired once per minute for (I) a 10min baseline, (II) after the
bath was switched to NMDA stimulation buffer (25mM HEPES,
120mM NaCl2, 5mM KCl, 2mM CaCl2, 0.2mM MgCl2, 30mM
D-glucose, 1mM TTX, 20mM NMDA, 10mM glycine, pH 7.4) for
5min to stimulate internalization, and (III), then following washout of
the NMDA stimulation buffer to monitor recycling back to the cell
surface. The pHluorin fluorescence was imaged at 488nm excitation,
while mCherry fluorescence was imaged at 559nm excitation, through
a  60 oil objective at a rate of one image per minute. Images were
analysed using ImageJ software (NIH) by straightening the primary
dendrite of the neuron, starting from the soma, and calculating the
fluorescence intensity relative to the average intensity of the baseline
period. The degree of GluA1 endocytosis was determined by analysing
the first 1–3min after NMDA stimulation (max decrease in signal) and
the rate of GluA1 recycling was determined by fitting a linear curve to
the time after max internalization and calculating the time point at
which 50% of fluorescence recovered. pHluorin-GluA1 was a gift of
Robert Malinow (Addgene plasmid #24000).
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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